Companies: 10,795·Total market cap: $144.5T
Humacyte, Inc.

Humacyte, Inc.

HUMANASDAQHealthcare● Active
$1.45
+$0.07(+5.07%)
Market Cap$243600000
P/E Ratio
52W High$2.84
52W Low$0.547
Overview

Humacyte, Inc. (HUMA) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · HUMA · as of 2026-06-10

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$50.50M$44.94M$80.45M$151.88M$225.50M
Net Receivables$0.44M$0.00M$0.00M$0.03M$0.18M
Inventory$13.59M$0.00M$0.00M$0.00M$0.00M
Total Current Assets$67.80M$47.86M$83.28M$154.21M$229.34M
PP&E Net$47.69M$38.55M$44.10M$50.09M$57.19M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.00M$0.00M$0.00M$0.00M$0.00M
Total Assets$116.37M$137.87M$128.22M$204.30M$286.53M
Liabilities
Short-Term Debt$2.43M$0.00M$0.00M$8.57M$0.00M
Accounts Payable$5.40M$4.49M$6.49M$1.59M$2.09M
Total Current Liabilities$18.37M$19.95M$18.44M$19.58M$11.05M
Long-Term Debt$35.44M$0.00M$38.60M$20.34M$27.36M
Total Liabilities$113.26M$190.54M$114.68M$87.37M$164.36M
Stockholders Equity
Retained Earnings($726.85M)($686.01M)($537.31M)($426.54M)($414.57M)
Total Stockholders Equity$3.11M($52.67M)$13.55M$116.93M$122.17M
Total Liab & Equity(computed)$116.37M$137.87M$128.22M$204.30M$286.53M
Debt Summary
Total Debt$64.85M$16.54M$57.45M$50.07M$51.18M
Net Debt$14.35M($28.40M)($23.00M)($99.71M)($166.32M)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M

Explore more Humacyte, Inc. data

About Humacyte, Inc. (HUMA) Balance Sheet

Humacyte, Inc. (HUMA) balance sheet shows total assets of $0.12B with cash of $0.05B. Total liabilities are $0.11B, total debt $0.06B, and stockholders equity $0.00B.

Frequently asked questions

HUMA · 4 questions

Humacyte, Inc. has total debt of $0.06B with net debt of $0.01B.

HUMA total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10